other
confidence high
sentiment neutral
materiality 0.25
Aptevo shareholders approve reverse stock split and Yorkville equity issuance
Aptevo Therapeutics Inc.
- Elected directors Marvin L. White (443,945 for) and John E. Niederhuber (444,661 for) to board.
- Approved reverse stock split at ratio 1:6 to 1:20, board to set timing and exact ratio.
- Approved issuance of >19.99% of outstanding shares under SEPA with YA II PN, Ltd. (Yorkville).
- Approved Third Amended and Restated 2018 Stock Incentive Plan and non-binding advisory say-on-pay.
- Ratified Baker Tilly as independent auditor for fiscal 2025.
item 5.07